Abstract
Neuromuscular complications acquired in the intensive care unit form a new clinical entity. Three neuromuscular deficits are described: so-called critical illness polyneuropathy where neuromyopathic changes are associated with corticosteroid and/or neuromuscular blocking agents, and catabolic myopathy. We report four new cases: three of them concerning polyneuropathy and one neuromyopathic change.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adrenal Cortex Hormones / adverse effects
-
Adult
-
Aged
-
Biomarkers
-
Creatine Kinase / blood
-
Critical Care*
-
Curare / adverse effects
-
Demyelinating Diseases / chemically induced
-
Demyelinating Diseases / etiology*
-
Diabetes Mellitus, Type 2 / complications
-
Electromyography
-
Female
-
Heart Arrest / complications
-
Humans
-
Ischemia / etiology
-
Isoenzymes
-
Male
-
Middle Aged
-
Multiple Organ Failure / complications
-
Neural Conduction
-
Neuromuscular Diseases / chemically induced
-
Neuromuscular Diseases / etiology*
-
Neuromuscular Nondepolarizing Agents / adverse effects
-
Paralysis / etiology
-
Paralysis / physiopathology
-
Peripheral Nerves / blood supply
-
Polyneuropathies / chemically induced
-
Polyneuropathies / etiology*
-
Reflex, Abnormal
-
Respiratory Muscles / physiopathology
Substances
-
Adrenal Cortex Hormones
-
Biomarkers
-
Isoenzymes
-
Neuromuscular Nondepolarizing Agents
-
Curare
-
Creatine Kinase